Nuveen’s Pfizer PFE Stock Holding History

Nuveen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,350	Closed	-$1K	–	3336
2020 Q2	$1K	Buy	+26,350	New	+$895K	﹤0.01%	3263
2016 Q1	–	Sell	-5,270	Closed	-$161	–	1473
2015 Q4	$161	Sell	5,270 -6,324	-55%	-$199K	﹤0.01%	1458
2015 Q3	$346	Hold	11,594	–	–	﹤0.01%	1395
2015 Q2	$369	Sell	11,594 -10,540	-48%	-$344K	﹤0.01%	1433
2015 Q1	$731K	Sell	22,134 -54,808	-71%	-$1.74M	﹤0.01%	1270
2014 Q4	$2.27M	Buy	76,942 +1,054	+1%	+$30.2K	0.01%	789
2014 Q3	$2.13M	Hold	75,888	–	–	0.01%	797
2014 Q2	$2.14M	Buy	75,888 +2,108	+3%	+$60.1K	0.01%	795
2014 Q1	$2.25M	Sell	73,780 -36,890	-33%	-$1.1M	0.01%	760
2013 Q4	$3.22M	Sell	110,670 -18,972	-15%	-$552K	0.02%	617
2013 Q3	$4.02M	Sell	129,642 -35,836	-22%	-$975K	0.03%	574
2013 Q2	$4.4M	Buy	+165,478	New	+$4.57M	0.03%	542

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nuveen's PFE Position: Q1 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 0.11% in Q1 2026, buying an estimated $386K and bringing the position to 13,178,661 shares worth $370M. The position accounts for 0.1% of the portfolio, ranked #163.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.66B in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Nuveen held 13,178,661 shares of Pfizer worth $370M as of Q1 2026.
Nuveen bought 14,511 Pfizer shares in Q1 2026, an estimated $386K.
Pfizer made up 0.1% of Nuveen's portfolio in Q1 2026, its #163 holding.
Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.